Zurcher Kantonalbank Zurich Cantonalbank Sells 767 Shares of MAXIMUS, Inc. (MMS)

Zurcher Kantonalbank Zurich Cantonalbank lessened its holdings in MAXIMUS, Inc. (NYSE:MMS) by 17.6% during the 1st quarter, Holdings Channel reports. The firm owned 3,594 shares of the health services provider’s stock after selling 767 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank’s holdings in MAXIMUS were worth $255,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also modified their holdings of the company. BlackRock Inc. boosted its stake in shares of MAXIMUS by 1.1% in the 4th quarter. BlackRock Inc. now owns 7,371,490 shares of the health services provider’s stock valued at $479,810,000 after purchasing an additional 81,788 shares during the last quarter. Vanguard Group Inc boosted its stake in shares of MAXIMUS by 0.8% in the 3rd quarter. Vanguard Group Inc now owns 6,767,684 shares of the health services provider’s stock valued at $440,305,000 after purchasing an additional 52,238 shares during the last quarter. Victory Capital Management Inc. boosted its stake in shares of MAXIMUS by 1.3% in the 4th quarter. Victory Capital Management Inc. now owns 4,011,882 shares of the health services provider’s stock valued at $261,133,000 after purchasing an additional 51,283 shares during the last quarter. Mackenzie Financial Corp boosted its stake in shares of MAXIMUS by 17.6% in the 4th quarter. Mackenzie Financial Corp now owns 1,853,213 shares of the health services provider’s stock valued at $120,626,000 after purchasing an additional 277,775 shares during the last quarter. Finally, Oregon Public Employees Retirement Fund boosted its stake in shares of MAXIMUS by 6,329.9% in the 4th quarter. Oregon Public Employees Retirement Fund now owns 1,656,085 shares of the health services provider’s stock valued at $25,000 after purchasing an additional 1,630,329 shares during the last quarter. 95.81% of the stock is currently owned by institutional investors.

Several research analysts have recently issued reports on the stock. Zacks Investment Research raised shares of MAXIMUS from a “sell” rating to a “hold” rating in a research note on Monday, May 6th. ValuEngine lowered shares of MAXIMUS from a “buy” rating to a “hold” rating in a research note on Thursday, February 28th.

Shares of NYSE:MMS opened at $71.27 on Thursday. The company has a market capitalization of $4.55 billion, a P/E ratio of 20.96, a PEG ratio of 1.92 and a beta of 0.96. The company has a debt-to-equity ratio of 0.06, a quick ratio of 2.31 and a current ratio of 2.31. MAXIMUS, Inc. has a fifty-two week low of $60.00 and a fifty-two week high of $74.18.

MAXIMUS (NYSE:MMS) last announced its quarterly earnings results on Thursday, May 9th. The health services provider reported $0.96 earnings per share for the quarter, beating analysts’ consensus estimates of $0.91 by $0.05. The business had revenue of $736.50 million for the quarter, compared to the consensus estimate of $757.29 million. MAXIMUS had a net margin of 8.76% and a return on equity of 21.19%. MAXIMUS’s revenue for the quarter was up 20.2% on a year-over-year basis. During the same period last year, the company posted $0.84 EPS. On average, analysts forecast that MAXIMUS, Inc. will post 3.72 EPS for the current fiscal year.

The company also recently declared a quarterly dividend, which will be paid on Friday, May 31st. Investors of record on Wednesday, May 15th will be given a $0.25 dividend. The ex-dividend date is Tuesday, May 14th. This represents a $1.00 dividend on an annualized basis and a dividend yield of 1.40%. MAXIMUS’s dividend payout ratio is 29.41%.

In related news, Vice Chairman Richard A. Montoni sold 12,000 shares of the stock in a transaction that occurred on Tuesday, March 12th. The shares were sold at an average price of $70.69, for a total value of $848,280.00. Following the sale, the insider now directly owns 412,874 shares in the company, valued at approximately $29,186,063.06. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Vice Chairman Richard A. Montoni sold 35,000 shares of the stock in a transaction that occurred on Thursday, March 14th. The shares were sold at an average price of $70.97, for a total transaction of $2,483,950.00. Following the completion of the sale, the insider now owns 412,874 shares in the company, valued at $29,301,667.78. The disclosure for this sale can be found here. Insiders sold a total of 48,000 shares of company stock worth $3,403,630 over the last quarter. 2.20% of the stock is currently owned by corporate insiders.

TRADEMARK VIOLATION WARNING: This piece of content was first posted by WKRB News and is owned by of WKRB News. If you are accessing this piece of content on another website, it was illegally stolen and reposted in violation of United States & international copyright law. The correct version of this piece of content can be read at https://www.wkrb13.com/2019/05/16/zurcher-kantonalbank-zurich-cantonalbank-sells-767-shares-of-maximus-inc-mms.html.

MAXIMUS Profile

MAXIMUS, Inc provides business process services (BPS) to government health and human services programs worldwide. The company's Health Services segment offers various BPS, appeals, and assessments for state, provincial, and national government programs, including Medicaid, Children's Health Insurance Program, Affordable Care Act, Health Insurance British Columbia, Health Assessment Advisory Service contract, and Preadmission Screening and Resident Reviews.

Featured Story: Bollinger Bands

Want to see what other hedge funds are holding MMS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MAXIMUS, Inc. (NYSE:MMS).

Institutional Ownership by Quarter for MAXIMUS (NYSE:MMS)

Receive News & Ratings for MAXIMUS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MAXIMUS and related companies with MarketBeat.com's FREE daily email newsletter.